Premium Nahrungsergänzungsmittel | artgerecht

Alkylating Agents – Mechanism, Uses & Side Effects

Alkylating agents are cytostatic drugs that damage the DNA of cancer cells, preventing them from dividing. They are among the oldest and most important drug classes in cancer therapy.

Regular tips about health Regular tips about health

Things worth knowing about "Alkylating Agents"

Alkylating agents are cytostatic drugs that damage the DNA of cancer cells, preventing them from dividing. They are among the oldest and most important drug classes in cancer therapy.

What Are Alkylating Agents?

Alkylating agents are a group of drugs used primarily in chemotherapy to treat various types of cancer. They work by attaching chemical alkyl groups to the DNA (genetic material) of cells, thereby disrupting cell division. Because cancer cells divide particularly rapidly, they are especially vulnerable to this class of drugs.

Mechanism of Action

The central mechanism of alkylating agents involves the covalent binding of an alkyl group to the DNA of the target cell. The DNA base guanine is most frequently attacked, resulting in:

Crosslinks within a single DNA strand (intrastrand crosslinks)
Crosslinks between two DNA strands (interstrand crosslinks)
Single-strand breaks in the DNA

These forms of DNA damage prevent the genetic code from being correctly read and replicated. The affected cell can no longer divide and ultimately dies through programmed cell death (apoptosis).

Classification and Key Agents

Alkylating agents are divided into several subgroups:

Nitrogen Mustards (Chlorambucil, Cyclophosphamide, Ifosfamide, Melphalan)

This group has historical roots in mustard gas research and includes important agents such as cyclophosphamide, which is widely used in lymphomas, leukemias, and solid tumors.

Nitrosoureas (Carmustine, Lomustine)

These agents are highly lipophilic (fat-soluble) and can cross the blood-brain barrier. They are therefore preferred for the treatment of brain tumors.

Alkyl Sulfonates (Busulfan)

Busulfan is primarily used in conditioning regimens before stem cell transplantation.

Platinum Compounds (Cisplatin, Carboplatin, Oxaliplatin)

Although they do not transfer classical alkyl groups, platinum compounds act through a similar principle by forming DNA crosslinks and are functionally classified alongside alkylating agents.

Triazenes and Hydrazines (Dacarbazine, Temozolomide)

Temozolomide is taken orally and is a standard treatment for glioblastoma, one of the most aggressive forms of brain cancer.

Indications

Alkylating agents are used in the treatment of numerous cancers, including:

Lymphomas (Hodgkin and non-Hodgkin lymphoma)
Leukemias (e.g., chronic lymphocytic leukemia)
Multiple myeloma
Breast and ovarian cancer
Brain tumors (e.g., glioblastoma)
Lung cancer and other solid tumors

Side Effects

Because alkylating agents do not act exclusively on cancer cells but also damage healthy, rapidly dividing cells, they can cause significant side effects:

Myelosuppression: Suppression of bone marrow activity, leading to anemia, increased susceptibility to infection, and bleeding tendencies
Nausea and vomiting
Hair loss (alopecia)
Mucositis: Inflammation of the mucous membranes
Gonadotoxicity: Impairment of fertility in both men and women
Secondary malignancies: The DNA-damaging properties increase the risk of developing new cancers later in life
Organ-specific toxicities, such as hemorrhagic cystitis with cyclophosphamide or nephrotoxicity with cisplatin

Resistance Mechanisms

The development of resistance to alkylating agents is a clinically significant challenge. Cancer cells can develop mechanisms to repair DNA damage or actively expel the drugs from the cell. Key resistance mechanisms include the upregulation of DNA repair enzymes and enhanced detoxification activity via systems such as glutathione.

References

DeVita, V.T., Lawrence, T.S., Rosenberg, S.A. (2019). DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 11th Edition. Wolters Kluwer.
Brunton, L.L., Hilal-Dandan, R., Knollmann, B.C. (2017). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 13th Edition. McGraw-Hill Education.
National Cancer Institute (NCI): Alkylating Agents. URL: https://www.cancer.gov/about-cancer/treatment/types/chemotherapy (accessed 2024)

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category